Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
NovaBridge Biosciences (NBP) had Cash Flow from Financial Activities of $0.74M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$198.00M |
|
$1.27M |
|
$33.54M |
|
$231.54M |
|
$25.92M |
|
-- |
|
$4.52M |
|
$30.44M |
|
$201.10M |
|
$201.10M |
|
$201.10M |
|
116.00M |
|
| Cash Flow Statement Financials | |
$-32.93M |
|
$12.24M |
|
|
Cash Flow from Financial Activities |
$0.74M |
$210.63M |
|
$190.64M |
|
$-20.00M |
|
$6.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|